Management of intermediate‐risk pulmonary embolism: uncertainties and challenges
Population
Hemodynamically stable patients with acute pulmonary embolism stratified as 'intermediate risk'
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Risk stratification informs PE treatment choices in stable patients; leaves open optimal strategies for intermediate-risk cases.
Structured PICO
P
Population
Hemodynamically stable patients with acute pulmonary embolism stratified as 'intermediate risk'
I
Intervention
Reperfusion therapy and non-vitamin K-dependent oral anticoagulants (NOACs)
This clinical review highlights the identification of intermediate-risk pulmonary embolism patients and discusses indications for reperfusion therapy and NOAC use.
Cite This Study
Klok et al. (2015) studied this question.